These updates are republished press releases and communications from members of the Science|Business Network. Network Updates can be sent to [email protected] and [email protected]. To know if your content piece qualifies as Network Update, check the editorial guidelines here.

Innovation Angels target Norwegian market

Scientific Generics, the technology consultancy based in Cambridge, UK, has exported its 'Innovation Angels' methodology to Oslo in a pilot programme supported by the industrial development agency Innovation Norway.

Biotech: the Greens won't stop it

Marc Van Montagu, Europe's founding father of genetically modified crops and a powerful advocate for their acceptance in Europe, speaks to Science|Business News Editor Thomas Lau.

Lein raises 3rd funding from Seven Spires; seeks more investment

Lein Applied Diagnostics, a British company that develops blood glucose measuring for people with diabetes, has announced it has received further investment from its shareholder Seven Spires Investments. The company is seeking more investment to put a non-invasive blood glucose meter into clinical trials.

Stem cell scandal: shockwaves hit UK

The UK's stem cell community has reacted with collective dismay at the final confirmation that Hwang Woo-suk's claims to have generated patient-specific embryonic stem cell lines were fraudulent. Nuala Moran takes a look.

The rise of the European business angel

The concept of angel investing - in which individuals devote both their time and money to nurturing young companies - has evolved over the past decade from an unknown or poorly understand phenomena in many parts of Europe to an established form of finance.